Comparison of 1-Year Clinical Course in Patients With Newly Diagnosed Inflammatory Bowel Disease Between Vietnam and Korea: A Multinational, Multicenter Retrospective Cohort Study

  • Dang, Luan Minh; 
  • Kim, Eun Soo; 
  • Kim, Kyeong Ok; 
  • Lee, Yoo Jin; 
  • Bui, Hoang Huu; 
  • 외 8명
Citations

WEB OF SCIENCE

2
Citations

SCOPUS

1

초록

Background/Aims The differences in the clinical course of Crohn's disease (CD) and ulcerative colitis (UC) among Asian countries remain unknown. Thus, we compared the clinical characteristics, treatment, and one-year outcomes of newly diagnosed inflammatory bowel disease (IBD) patients between Vietnam and Korea. Methods A retrospective cohort study was conducted at seven tertiary hospitals in these countries between January 2020 and January 2021. Data on demographics, diseases, treatment, and outcomes during 1 year after diagnosis were collected. Results Among 225 patients (60 from Vietnam and 165 from Korea), 140 and 85 were diagnosed with UC and CD, respectively. Severe activity (p < 0.01) and extensive colitis (p < 0.01) in UC, along with complicated behavior in CD (p < 0.01), were more frequently observed in Vietnamese patients compared to Korean patients. The proportion of UC patients using corticosteroids (p < 0.01), immunomodulators (p < 0.01), and biologics (p = 0.026) was significantly higher in Vietnam. In contrast, the proportion of UC patients using topical mesalamine (p < 0.01) was significantly higher in Korea. The intervals from CD diagnosis to biologic therapy initiation (p = 0.04), as well as from UC diagnosis to corticosteroid (p < 0.01), immunomodulator (p < 0.01), and biologic therapy (p < 0.01) commencement, were significantly shorter in Vietnamese patients compared to Korean patients. However, the proportions of endoscopic healing and complications at 1-year follow-up did not significantly differ between the countries (p > 0.05). Conclusions Although Vietnamese IBD patients had higher baseline clinical and phenotypic severity than their Korean counterparts, no significant differences in short-term outcomes were observed, potentially reflecting the impact of the higher rate and early biologic usage in Vietnamese patients.

키워드

Crohn's disease; inflammatory bowel disease; Korea; ulcerative colitis; Vietnam; ANTI-TNF THERAPY; ULCERATIVE-COLITIS; CROHNS-DISEASE; NECROSIS FACTOR; ASIAN PATIENTS; MANAGEMENT; GUIDELINES; EPIDEMIOLOGY; PHENOTYPE; CONSENSUS
제목
Comparison of 1-Year Clinical Course in Patients With Newly Diagnosed Inflammatory Bowel Disease Between Vietnam and Korea: A Multinational, Multicenter Retrospective Cohort Study
저자
Dang, Luan Minh; Kim, Eun Soo; Kim, Kyeong Ok; Lee, Yoo Jin; Bui, Hoang Huu; Nguyen, Chuong Dinh; Nguyen, Chi Thi; Nguyen, Nam Hoai; Nguyen, Hien Thi-Thu; Dinh, Nga Thi; Nguyen, Lien Thi-Phuong; Vu, Khien Van; Duong, Minh Cuong
DOI
10.1002/jgh3.70106
발행일
2025-02
유형
Article
저널명
JGH OPEN
권
9
호
2